Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades *

HIV‐1 non‐B subtypes have recently entered Western Europe following immigration from other regions. The distribution of non‐B clades and their association with demographic factors, over the entire course of the HIV‐1 epidemic, have not been fully investigated in Italy.

[1]  R. Lalonde,et al.  Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare , 2009, AIDS.

[2]  J. Martínez-Cajas,et al.  Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996–2008) , 2009, Journal of the International AIDS Society.

[3]  David Dunn,et al.  Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals , 2009, Journal of Virology.

[4]  Á. Holguín,et al.  Performance of Three Commercial Viral Load Assays, Versant Human Immunodeficiency Virus Type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, Testing HIV-1 Non-B Subtypes and Recombinant Variants , 2008, Journal of Clinical Microbiology.

[5]  F. Baldanti,et al.  Changes in circulation of B and non‐B HIV strains: Spotlight on a reference centre for infectious diseases in Northern Italy , 2008, Journal of medical virology.

[6]  S. Hammer,et al.  The challenge of HIV-1 subtype diversity. , 2008, The New England journal of medicine.

[7]  Spread programme,et al.  Transmission of drug-resistant HIV-1 in Europe remains limited to single classes , 2008, AIDS.

[8]  Jörg Schüpbach,et al.  Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey , 2007, AIDS.

[9]  M. T. Paixão,et al.  Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[10]  E. Arts,et al.  Natural Variation in the V3 Crown of Human Immunodeficiency Virus Type 1 Affects Replicative Fitness and Entry Inhibitor Sensitivity , 2007, Journal of Virology.

[11]  Wei Huang,et al.  Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations , 2007, Journal of Virology.

[12]  M. Zazzi,et al.  Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy. , 2007, AIDS research and human retroviruses.

[13]  P. Ghys,et al.  Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004 , 2006, AIDS.

[14]  D. Pillay,et al.  Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003 , 2005, Journal of acquired immune deficiency syndromes.

[15]  M. Thomson,et al.  Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. , 2005, AIDS reviews.

[16]  P. Lemey,et al.  Molecular Footprint of Drug-Selective Pressure in a Human Immunodeficiency Virus Transmission Chain , 2005, Journal of Virology.

[17]  Klaus Korn,et al.  Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. , 2005, The Journal of infectious diseases.

[18]  Á. Holguín,et al.  HIV‐1 subtypes in Spain: a retrospective analysis from 1995 to 2003 , 2005, HIV medicine.

[19]  P. Musoke,et al.  Comparison of Mother-to-Child Transmission Rates in Ugandan Women With Subtype A Versus D HIV-1 Who Received Single-Dose Nevirapine Prophylaxis: HIV Network for Prevention Trials 012 , 2005, Journal of acquired immune deficiency syndromes.

[20]  E. Arts,et al.  The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates , 2005, Journal of Virology.

[21]  F. Mazzotta,et al.  HIV‐1 subtypes and circulating recombinant forms (CRFs) from HIV‐infected patients residing in two regions of central and southern Italy , 2005, Journal of medical virology.

[22]  Amilcar Tanuri,et al.  Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. , 2004, AIDS research and human retroviruses.

[23]  A. Vandamme,et al.  Rising Prevalence of HIV-1 Non-B Subtypes in Belgium: 1983–2001 , 2004, Journal of acquired immune deficiency syndromes.

[24]  F. Brun-Vézinet,et al.  Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France , 2003, AIDS.

[25]  M. Thomson,et al.  Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. , 2002, The Lancet. Infectious diseases.

[26]  M. Zazzi,et al.  Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[27]  M. Moroni,et al.  Increasing Prevalence of Non‐Clade B HIV‐1 Strains in Heterosexual Men and Women, as Monitored by Analysis of Reverse Transcriptase and Protease Sequences , 2001, Journal of acquired immune deficiency syndromes.

[28]  M. Moroni,et al.  Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. , 2001 .

[29]  J. Goudsmit,et al.  Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. , 2000, AIDS research and human retroviruses.

[30]  E. Magiorkinis,et al.  Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. , 1999, AIDS research and human retroviruses.

[31]  F. McCutchan,et al.  A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. , 1998, AIDS research and human retroviruses.

[32]  M. Zazzi,et al.  Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors , 1998, Molecular biotechnology.

[33]  J. Giesecke,et al.  Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. , 1997, AIDS research and human retroviruses.

[34]  D. Vlahov,et al.  Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. , 1996, AIDS research and human retroviruses.

[35]  P. Sharp,et al.  Recombination in HIV-1 , 1995, Nature.

[36]  Anne-Mieke Vandamme,et al.  Edinburgh Research Explorer Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1 , 2007 .

[37]  Brian T. Foley,et al.  HIV-1 Subtype and Circulating Recombinant Form (CRF) Reference Sequences, 2005 , 2005 .